{"title": "Pharma firms boost lobbying in race for coronavirus treatment, vaccine", "author": "Bloomberg", "url": "https://www.livemint.com/companies/news/pharma-firms-boost-lobbying-in-race-for-coronavirus-treatment-vaccine-11595306549683.html", "hostname": "livemint.com", "description": "Gilead Sciences reports $1.26 million in lobbying spending in the three months ending June 30.Moderna spends a company record $70,000 on lobbying in the second quarter, up from the $10,000 it spent in the same period a year ago", "sitename": "Mint", "date": "2020-07-21", "cleaned_text": "10:26 AM IST] Pharma firms boost lobbying in race for coronavirus treatment, vaccine Gilead Sciences reports $1.26 million in lobbying spending in the three months ending June 30 Moderna spends a company record $70,000 on lobbying in the second quarter, up from the $10,000 it spent in the same period a year ago [] Several drugmakers bolstered their federal lobbying in the second quarter of the year as the coronavirus pandemic created an urgent and potentially lucrative race for medicines, vaccine research and new tests. Next Story Feedback Select your Category Your Message "}